Generic cancer drug put to the test
NCT ID NCT06326697
Summary
This study tested if a new generic version of the drug azacitidine works the same in the body as the existing brand-name version (Onureg). It involved 32 adults with a type of blood cancer called acute myeloid leukemia (AML) who were in remission. The main goal was to see if the two drug versions produced similar levels of medication in the blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
King Faisal Specialist Hospital and Research Centre
Riyadh, Saudi Arabia
Conditions
Explore the condition pages connected to this study.